RHOADS ANN D 4
4 · QuidelOrtho Corp · Filed Jun 2, 2026
Research Summary
AI-generated summary of this filing
QuidelOrtho (QDEL) Director Ann Rhoads Receives RSU Award
What Happened
Ann D. Rhoads, a director of QuidelOrtho Corporation (QDEL), had 6,829 restricted stock units (RSUs) vest on May 29, 2026. The RSUs were converted into 6,829 shares of common stock (award A and derivative conversion M). No cash was paid on conversion (reported price $0.00).
Key Details
- Transaction date: May 29, 2026 (reported on Form 4 filed June 2, 2026).
- Instruments and amounts: 6,829 RSUs released (footnote F1); 6,829 shares acquired via conversion of derivative (footnote F3).
- Price: $0.00 per share reported (RSUs converted to shares without an exercise price).
- Total cash exchanged: $0 (shares issued on vesting).
- Shares owned after transaction: not disclosed in the provided filing excerpt.
- Footnotes: F1 = release of previously reported RSUs; F2 = each RSU equals one share; F3 = RSUs vested on May 29, 2026.
- Timeliness: Form 4 filed June 2, 2026; the filing does not indicate a late-report flag in the provided data.
Context
This was a grant/vesting event (RSU release and conversion to shares), not an open-market purchase or sale. Such vested-share issuances are routine compensation for directors and do not in themselves indicate a buy or sell signal. The derivative code (M) simply reflects conversion/exercise of a derivative award (the RSUs) into ordinary shares.
Insider Transaction Report
- Award
Common Stock
[F1]2026-05-29+6,829→ 23,257 total - Exercise/Conversion
Restricted Stock Units (Equity Grant)
[F2][F3]2026-05-29−6,829→ 0 total→ Common Stock (6,829 underlying)
Footnotes (3)
- [F1]Reflects release of restricted stock units that were previously reported on a Form 4.
- [F2]Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
- [F3]The restricted stock units vested on May 29, 2026.